RenovoRx, Inc. (RNXT) Stock Forecast
Data as of Sep 19, 2026Healthcare · Current price $1.71 (-1.45%)
Consensus Target
—
Upside
—
Analysts
4
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
RNXT vs Sector & Market
| Metric | RNXT | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 4 | 8 | 18 |
| Target Upside | — | +22217.1% | +21.5% |
| P/E Ratio | -2.66 | 3.76 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3M | $4M | $4M | 2 |
| 2027-12-31 | $9M | $11M | $13M | 2 |
| 2028-12-31 | $33M | $35M | $36M | 3 |
| 2029-12-31 | $128M | $156M | $191M | 2 |
| 2030-12-31 | $291M | $354M | $433M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.26 | $-0.23 | $-0.20 | 1 |
| 2027-12-31 | $-0.19 | $-0.15 | $-0.12 | 2 |
| 2028-12-31 | $-0.03 | $-0.01 | $0.03 | 3 |
| 2029-12-31 | $0.64 | $0.84 | $1.08 | 1 |
| 2030-12-31 | $1.81 | $2.35 | $3.04 | 1 |
Frequently Asked Questions
What is the analyst consensus for RNXT?
The consensus among 4 analysts covering RenovoRx, Inc. (RNXT) is Buy with an average price target of N/A.
How many analysts cover RNXT?
4 analysts have issued ratings for RenovoRx, Inc. in the past 12 months.
Is RNXT a buy or sell right now?
Based on 4 analyst ratings, RNXT has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for RNXT?
Analysts estimate RNXT will report EPS of $-0.23 for the period ending 2026-12-31, with revenue estimated at $4M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.